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Binding of enzymatic E colicins to the vitamin B12 receptor, BtuB, is
the first stage in a cascade of events that culminate in the
translocation of the cytotoxic nuclease into the Escherichia coli
cytoplasm and release of its tightly bound immunity protein. A
dogma of colicin biology is that the toxin coiled-coil connecting its
functional domains must unfold or unfurl to span the periplasm,
with recent reports claiming this reaction is initiated by receptor
binding. We report isothermal titration calorimetry data of BtuB
binding the endonuclease toxin ColE9 and a disulfide form
(ColE9S-S) where unfolding of the coiled-coil is prevented and, as a
consequence, the toxin is biologically inactive. Contrary to expec-
tation, the thermodynamics of receptor binding, characterized by
large negative values for TS, are identical for the two colicins,
arguing against any form of BtuB-induced unfolding. We go on to
delineate key features of the ‘‘colicin translocon’’ that assembles at
the cell surface after BtuB binding by using a complex of histidine-
tagged Im9 bound to ColE9S-S. First, we show that the porin OmpF
is recruited directly to the BtuBcolicin complex to form the trans-
locon. Second, recruitment is through the natively unfolded region
of the colicin translocation domain, with this domain likely having
two contact points for OmpF. Finally, the immunity protein is not
released during its assembly. Our study demonstrates that al-
though colicin unfolding is undoubtedly a prerequisite for E. coli
cell death, it must occur after assembly of the translocon.
colicin  toxin  outer membrane  translocation  native disorder
Protein translocation involves the movement of proteins be-tween cellular compartments. Essential for secretion, pro-
tein translocation also underpins the ability of microbial toxins
to penetrate cells. Both secretion and toxin import rely on
protein assemblies to provide the conduit for the translocating
polypeptide. In contrast to secretion, however, where these
conducting complexes have evolved to facilitate translocation,
protein toxins parasitize normal host cell processes, exemplified
by the translocation of microbial toxins into eukaryotic cells (1)
and by the import of bacteriocins into prokaryotes (2). Primarily
expressed during times of stress, bacteriocins are protein anti-
biotics made by most species of bacteria that play a pivotal role
in microbial colonization, competition, and diversification (3, 4).
Given the potency of bacteriocins (they exhibit single-hit kinet-
ics) and their exquisite cellular specificity, understanding how
they penetrate bacterial cells offers new opportunities for the
design of antimicrobial agents and provides novel ways of
probing the function of host proteins that are parasitized by
them. However, bacteriocin translocation is poorly understood.
In the present work, we answer some of the key questions
concerning early events in the cellular import of colicins, bac-
teriocins specific for Escherichia coli.
Colicins enter cells by coopting a number of proteins in the
E. coli outer envelope, including an outer membrane receptor
and one or more periplasmic proteins (5, 6). The outer mem-
brane receptors are nutrient receptors, normally engaged either
in the passive import of small molecules or in the active transport
of complex molecules such as chelated iron or vitamin B12
(cobalamin) into the cell. Consequently, such receptor systems
are an ‘‘Achilles heel’’ for the bacterium, exploited by filamen-
tous bacteriophage and colicins as a gateway into the cell (7).
As well as traversing the outer membrane, colicins must also
find a way through the periplasm. Accomplishing both feats
involves recruitment of either the TonBExbBExbD complex,
specific for group B colicins such as Ia, Ib, B, and D, or the
TolQRABPal complex, utilized by group A colicins such as
E2-E9, N, and A (5, 8). Both the Ton and Tol systems are
coupled to the protonmotive force across the inner membrane,
acting as energy transducers for active transport (Ton) or
maintenance of outer envelope integrity (Tol) (9). It is generally
thought that colicins tap into the energy associated with these
systems to translocate into cells although how this mechanism is
accomplished is not known.
Colicins most commonly elicit cell death through depolariza-
tion of the inner membrane by an ionophore (Ia, Ib, E1, N, A,
and B) or through nuclease action that targets cytoplasmic DNA
(E2 and E7-E9), rRNA (E3, E4, and E6) or tRNA (E5 and D).
We have been studying the cell-entry mechanism of that, as with
all E colicins, uses the cobalamin receptor BtuB as its primary
outer membrane receptor (10). ColE9 is a 60-kDa group A
colicin that delivers a metal-dependent endonuclease (related to
the apoptotic nuclease, CAD) to the cytosol, causing cell death
through nonspecific degradation of the bacterial genome (6).
Colicins have hairpin-like structures, characterized by that of the
rRNase colicin ColE3 (11) (Fig. 1) and the ionophore ColIa (14).
These toxins comprise a central receptor-binding (R) domain
flanked by N-terminal translocation (T) and C-terminal cell-
killing domains, the latter two in close proximity and separated
from the R domain by a long coiled-coil. Colicins are thought to
unfold or unfurl to allow them to span the periplasm while
simultaneously contacting the outer membrane. Such large-scale
structural changes are supported by the data of Penfold et al.
(15), who showed that a constraining disulfide bond engineered
across the ColE9 R domain (Fig. 1) abolished toxin activity that
could be restored on reduction with DTT. Although colicin
unfolding is generally accepted as a part of the uptake mecha-
nism, uncertainty remains as to when such structural changes
occur, with one recent suggestion from Cramer and coworkers
that colicin unfolding is induced by BtuB binding (12, 16).
Focusing on the DNase ColE9, we have used isothermal
titration calorimetry (ITC) to test the hypothesis that E colicin
binding to the BtuB receptor causes toxin unfolding. We find
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that the thermodynamics of colicin BtuB complex formation are
not consistent with toxin unfolding but rather with increased
rigidification of the receptor. It is also unlikely colicins unfold
during assembly of the outer membrane translocon, which we
show involves the recruitment of OmpF to the BtuBcolicin
complex through a natively disordered domain of the toxin. We
conclude that the mechanism of colicin import into bacterial
cells needs to be reappraised in light of these data.
Materials and Methods
Protein Purification. BtuB was purified by using a protocol mod-
ified from that used by Law et al. (17). The cell pellet from a
5-liter culture of E. coli TNE012 cells (K12 tsx, ompA, ompB)
transformed with pNP278 (containing btuB under the control of
the arabinose promoter) was resuspended in 35 ml of 10 mM
TrisHCl, pH 8.00.25% (wt/vol) lithium diiodosalicylate in the
presence of Complete protease inhibitor mixture (Roche Diag-
nostics) and sonicated on ice. Cell debris was removed by
centrifugation at 5,000  g for 10 min, followed by centrifugation
of the supernatant at 200,000  g for 1 h at 4°C. Inner membrane
proteins were extracted from the total membrane pellet through
homogenization in 56 ml of 10 mM TrisHCl, pH 8.00.25%
(wt/vol) lithium diiodosalicylate2% (vol/vol) Triton X-100.
After centrifugation at 200,000  g for 1 h, the outer membrane
pellet was resuspended in 56 ml of 10 mM TrisHCl, pH 8.0,
followed by centrifugation at 200,000  g for 1 h at 4°C. Outer
membrane proteins were solubilized in 56 ml of 10 mM TrisHCl,
pH 8.0, containing 1% (wtvol) n-octyl--D-glucopyranoside
(-OG), centrifuged at 200,000  g for 1 h at 22°C, and the
extract was loaded onto a 4-ml DEAE-Sepharose anion ex-
change column equilibrated in 50 mM Tris-HCl, pH 7.5, 5 mM
EDTA, 0.54% -OG, 100 mM LiCl. After a 40 ml wash, BtuB
was eluted from the DEAE-Sepharose column with a 0.1–1.0 M
LiCl gradient. The final gel-filtration step of Law et al. (17) was
found to diminish the quantity of LPS associated with BtuB, with
a concurrent 50- to 100-fold decrease in the ability of exogenous
BtuB to protect susceptible cells from Col cytotoxicity. Although
efficient restoration of BtuB-mediated protection could be
achieved by the addition of LPS, the gel filtration step was
omitted because of the high purity of BtuB after anion exchange.
Purified pooled fractions were stored at 20°C.
Wild-type ColE9immunity protein 9 (Im9) and full-length
and truncated ColE9 with a disulfide bond between residues 324
and 447 within the R domain (ColE9S-S)Im9 complexes (con-
structed by PCR mutagenesis) were purified from pET21a
BL21(DE3) cell lysate through the hexa-histidine tag at the C
terminus of the immunity protein by using nickel affinity chro-
matography, followed by size exclusion chromatography, as
described in ref. 18.
All protein concentrations were determined although A280
measurements by using theoretical molar extinction coefficients
calculated from amino acid sequences.
Isothermal Titration Calorimetry. ITC measurements were per-
formed by using a MicroCal VP-ITC thermostated at 25°C.
Proteins were dialyzed overnight into 25 mM TrisHCl, pH
7.5150 mM NaCl1% -OG (supplemented with either 5 mM
EGTA or 5 mM CaCl2) by using a 25-kDa molecular mass cutoff
SpectraPor membrane. BtuB was typically present in the sam-
ple cell at a concentration of 1.2 M with 16 M ColE9Im9 in
the syringe. After an initial 2-l injection, 29 aliquots of 10 l
were titrated from the syringe into the sample cell. Binding
isotherms were analyzed by using the manufacturer’s software.
Purification of ColE9Im9 Outer Membrane Protein Complexes. Cell
pellets from a 2.5-liter arabinose-induced pNP278 BE3000
(ompF, ompC) culture were resuspended in 10 mM TrisHCl,
pH 8.00.25% (wt/vol) lithium diiodosalicylate in the presence of
15 mg of bait protein (ColE9S-SIm9 or derivative) (15) and
Complete protease inhibitor mixture to give a final volume of
35 ml. After incubation at 4°C for 1 h, cells were lysed by using
a French press and insoluble cell debris was removed by cen-
trifugation at 5,000  g for 10 min. The total membrane pellet
was harvested by centrifugation at 200,000  g for 1 h at 4°C.
Inner membrane proteins were extracted as described above.
Outer membrane proteins in complex with ColE9S-SIm9 were
resuspended from the remaining pellet in 20 mM TrisHCl, pH
8.025 mM NaCl5 mM imidazole5 mM EDTA1% -OG,
incubating for 12 h at 37°C with shaking before centrifugation at
200,000  g for 1 h at 22°C. The extract was buffer exchanged to
remove EDTA and loaded onto a 1-ml nickel-charged HisTrap
HP column (Amersham Pharmacia Biosciences) to capture the
ColE9S-SIm9 complex and associated proteins, utilizing the
hexa-histidine tag on the C terminus of Im9. Unbound proteins
were washed from the column with 10 column volumes of 20 mM
TrisHCl, pH 8.025 mM NaCl5 mM imidazole1% -OG,
followed by elution of bound proteins with a 5–300 mM imida-
zole gradient. Eluted fractions were analyzed by SDSPAGE,
with bands of interest being excised from the gel, trypsin
digested, and identified through MALDI-TOF MS (Applied
Biosystems 4700).
In Vivo Cytotoxicity Assay. Fifty-milliliter shake flask cultures of
LB supplemented with 100 gml ampicillin and 5 gml
ColE9S-SIm9 were inoculated with 400 l of colicin susceptible
JM83 pTrc99A overnight culture. Cultures were incubated at
37°C, with bacterial growth being monitored through OD600
measurements at 30-min intervals. Two hours after inoculation,
ColE9S-SIm9 constructs were activated through the addition of
DTT to a final concentration of 5 mM. Bacterial growth was
monitored for an additional 5.5 h.
Results
Thermodynamics of BtuBColE9Im9 Complex Formation and the In-
fluence of Ca2. Ca2 ions are known to bind to extracellular loops
of the BtuB receptor creating the high-affinity binding site for
cobalamin (19). The published structure for the E colicin
R-domain bound to BtuB is in the absence of Ca2 ions (12). We
performed ITC experiments in the presence and absence of Ca2
Fig. 1. Structure of ColE3Im3 modeled on that of the BtuBColE3 R-domain
complex (11, 12). The figure highlights the positions of the R and T domains of
the enzymatic E colicin, the C-terminal E3 rRNase bound to Im3, and the
locations of the T domain deletions that were engineered into an R-domain
disulfide bond variant of ColE9 (ColE9S-S). (Inset) Structure of the ColE9 DNase
Im9 complex (13). The asterisk shows where on the full-length colicin the
domain would be attached in ColE9Im9. ColE3 and ColE9 are 92% identical
in sequence up to this point.
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ions to probe the thermodynamics of colicinBtuB interactions
and to establish whether they were compatible with receptor-
induced unfolding of the toxin. In addressing these issues, we
initially used intact ColE9 bound to its immunity protein, Im9,
because it is in the form of a heterodimeric complex that
enzymatic E colicin bind to BtuB (ref. 20 and Fig. 1).
In the presence of 5 mM EGTA, the affinity of the
BtuBColE9Im9 complex was relatively modest, with a Kd of
153 nM, but increased 65-fold to 2.4 nM in the presence of 5 mM
Ca2 ions (Fig. 2). A similar relative increase in affinity was
noted by Mohanty et al. (21) in their spectroscopic study of a 34
amino acid R-domain peptide binding to BtuB, although the
measured affinities were 1 order of magnitude weaker. Calo-
rimetric data for ColE9Im9 binding to BtuB are summarized in
Table 1. The data show that the free energy of binding in the
absence of Ca2 (G  9.3 kcalmol1) is the net result of an
extremely large and favorable enthalpy (H  42 kcalmol1)
but an unfavorable entropy (TS  33 kcalmol1). We also
found that the presence of the nuclease-bound immunity protein
had little effect on these parameters (Table 1), suggesting
receptor binding does not disrupt interactions to the inhibitor.
This interpretation was confirmed by analytical gel-filtration
chromatography of the BtuBColE9Im9 complex, which
showed that Im9 remained bound to the colicin (data not
shown). The thermodynamic parameters are consistent with
significant ordering taking place within the confines of the
complex and the formation of several intermolecular hydrogen
bonds. Both suppositions are borne out by the structure of the
E colicin R-domainBtuB complex; several extracellular loops of
BtuB become ordered on binding to the E colicin R domain,
resulting in the burial of 1,500 Å2 accessible surface area and the
formation of nine intermolecular hydrogen bonds.
The thermodynamic basis for the increase in affinity of the
BtuBColE9Im9 complex in the presence of Ca2 (G  11.8
kcalmol1) is due to the reaction becoming even more exother-
mic (H  63 kcalmol1), with a concomitant increase in
negative entropy (TS  51 kcalmol1). These data imply that
colicin binding to Ca2-bound BtuB causes even greater struc-
tural remodeling of the binding site. Although no structure for
an R-domainBtuBCa2 complex is yet available, we note that
the conformations of two loops in the Ca2-bound state of BtuB
differ significantly from those in the colicin R-domain-bound
state (12, 22). This observation suggests that loop conformations
in the R-domainBtuBCa2 complex will differ to those seen in
the absence of Ca2.
Thermodynamics of BtuBColE9S-SIm9 Complex Formation Discount
Receptor-Induced Unfolding of the Colicin. The significant negative
entropy associated with ColE9Im9 binding the BtuB receptor
is counterintuitive. Kurisu et al. (12) have argued that enzy-
matic E colicin binding to BtuB results in disordering of the N-
and C-terminal ends of the R-domain, which might be ex-
pected to yield a positive entropy in ITC experiments. The
absence of such an effect could, however, be explained by the
negative entropy associated with ordering of BtuB extracellu-
lar loops masking the positive entropy associated with E colicin
unfolding. To assess the contribution of unfolding of the
colicin R-domain to the thermodynamics of receptor binding,
we used the conformationally restricted ColE9S-SIm9 com-
plex in ITC experiments. ColE9S-SIm9 has an inactivating
disulfide bond engineered across the distal end of the R-
domain, thereby preventing unfolding of its coiled-coil struc-
ture (Fig. 1 and ref. 15). As with wild-type colicin, binding of
ColE9S-SIm9 to BtuB is calcium dependent. Surprisingly,
however, the values for enthalpy, entropy, and free energy
(Ca2) are almost identical to those of the wild-type toxin
(Table 1). Hence, the calorimetric data for ColE9 and ColE9S-S
binding to BtuB demonstrate that no global changes occur in
the conformation of the toxin, ruling out the possibility that
binding to BtuB induces colicin unfolding.
Recruitment of OmpF to the BtuBColE9Im9 Complex by the Natively
Disordered Colicin T Domain. After binding to BtuB, specific
N-terminal sequences within E colicins must contact the
TolPal complex in the periplasm in order for the toxin to
translocate into the bacterium. In the case of the enzymatic
colicins E3 and E9, residues D35GSGW39 comprise the so-
called ‘‘TolB box’’ because they bind TolB and are essential for
biological activity (23, 24). Importantly, the TolB box is part
of a natively disordered domain of the T domain at the extreme
N terminus of the toxin (25), with similarly unstructured
regions found in other colicins (26). A central question then is
how these sequences are able to traverse the outer membrane
in order that they bind TolB. Enzymatic E colicins are known
Fig. 2. Representative ITC binding curves for the formation of the
BtuBColE9Im9 complex. (a) Titration of a 16 M ColE9Im9 complex into 1.2
M BtuB in 25 mM TrisHCl, pH 7.5150 mM NaCl1% -OG in the presence of
5 mM EGTA. (b) Equivalent titration of 16 M ColE9Im9 complex into 1.2 M
BtuB in 25 mM TrisHCl, pH 7.5150 mM NaCl1% -OG in the presence of 5 mM
CaCl2. Data were fitted to a single binding-site model. Derived thermody-
namic parameters for these complexes are listed in Table 1.
Table 1. Thermodynamic parameters for ColE9 binding the BtuB receptor
Colicins
Plus 5 mM EGTA Plus 5 mM CaCl2
ColE9Im9 ColE9 ColE9S-SIm9 ColE9Im9 ColE9 ColE9S-SIm9
N 0.89  0.01 0.99  0.01 0.82  0.01 0.94  0.01 0.94  0.04 0.90  0.02
Kd, nM 153  28 50.4  12.5 71.8  3.3 2.1  0.2 2.5  1.7 1.0  0.1
G, kcalmol1 9.3  0.1 10.1  0.1 9.7  0.0 11.8  0.1 11.2  0.2 12.3  0.0
H, kcalmol1 42.0  2.4 39.6  2.6 40.0  1.0 62.5  2.3 58.5  1.9 67.6  0.1
TS, kcalmol1 32.8  2.5 29.6  2.8 30.2  1.1 50.6  2.1 46.7  2.3 55.0  0.2
ITC parameters for ColE9, ColE9Im9 and ColE9S-SIm9 binding the BtuB receptor in the presence and absence of calcium at 25°C in
25 mM TrisHCl, pH 7.5150 mM NaCl1% (wtvol) -OG. The errors shown are those from duplicate measurements.








to require porins such as OmpF, in addition to BtuB, to elicit
cell death (27), suggesting that OmpF may offer a route into
the periplasm. Consistent with such an entry mechanism, the
channel activity of OmpF molecules reconstituted into planar
lipid bilayers is blocked by N-terminal sequences from ColE3,
implying that the lumen of the porin becomes occluded (12).
Currently, however, there is no evidence that an enzymatic E
colicin bound to BtuB in the outer membrane is able to recruit
OmpF, which would be a requirement for such a mechanism
to operate.
We addressed the issue of porin recruitment through affinity
purification of colicin-bound protein complexes extracted
from the outer membrane of E. coli, capitalizing on the
inability of ColE9S-S to enter and kill bacterial cells while still
binding BtuB. Purification of membrane-bound receptor com-
plexes was expedited by the hexa-histidine tag that had been
engineered onto the C terminus of Im9 in the ColE9S-SIm9
complex utilized throughout this study (Fig. 1). Milligram
quantities of the toxin were added to E. coli BE3000 cells, and
detergent solubilized toxin-bound complexes purified by Ni2
affinity chromatography, as described in Materials and Meth-
ods. A single absorbance peak (at 280 nm) was observed upon
elution of bound protein from the nickel-affinity column with
a linear imidazole gradient (Fig. 3a). After SDSPAGE and
MALDI-TOF MS of trypsin-digested gel bands, this peak was
shown to contain BtuB, Col E9, Im9, and OmpF. The amount
of trimeric OmpF recovered bound to the BtuBColE9 com-
plex was generally substoichiometric (estimated by densitom-
etry of SDS-polyacrylamide gels as 0.3  0.2 from eight
separate extractions), the low yield likely ref lecting a combi-
nation of weak binding and stringent extraction procedures.
Our data provide direct evidence that OmpF binds to the
BtuBColE9Im9 complex in the E. coli outer membrane.
We next delineated the regions of ColE9S-S responsible for
the recruitment of OmpF by using affinity purification as an
assay. Deletion of residues 1–316 (1–316 ColE9S-SIm9),
encompassing both the structured and unstructured regions of
the T domain (Fig. 1), still resulted in the purification of BtuB
from E. coli membranes but OmpF was lost entirely from the
complex (Fig. 3b). Importantly, deletion of just the disordered
T-domain sequences (1–83 ColE9S-SIm9) also resulted in
the complete loss of OmpF from the BtuBcolicin complex
(Fig. 3c). A critical role therefore of the natively disordered 83
amino acids in enzymatic colicins is to recruit OmpF to the
BtuBColE9Im9 complex in the outer membrane.
Diminished OmpF Recruitment to the BtuBColE9Im9 Outer Mem-
brane Complex Decreases the Efficiency of Cell Killing. To determine
which regions of the disordered T domain were necessary for OmpF
recruitment, seven additional truncations were made, removing
residues 1–7 (1–7 ColE9S-SIm9), 1–30 (1–30 ColE9S-SIm9),
1–38 (1–38 ColE9S-SIm9), 1–45 (1–45 ColE9S-SIm9), 1–53
(1–53 ColE9S-SIm9), 1–60 (1–60 ColE9S-SIm9) and 60–80
(60–80 ColE9S-SIm9). Recruitment of OmpF was lost entirely in
both the 1–60 and 60–80 deletions (data not shown). Intriguingly,
there was little difference between the 7 and 53 residue deletions
where OmpF was recruited but in reduced yield. Densitometric
scanning of SDS-polyacrylamide gels from duplicate experiments
indicated that, relative to full-length ColE9S-SIm9 extractions
carried out on the same batch of cells, only 14  4%, 15  2%, 9 
5%, 10  5%, and 9  5% OmpF was affinity-purified for 1–7
ColE9S-SIm9, 1–30 ColE9S-SIm9, 1–38 ColE9S-SIm9, 1–45
ColE9S-SIm9, and 1–53 ColE9S-SIm9 respectively (data not
shown). The data imply that distinct, noncontiguous regions of the
disordered T domain of the Col are required for OmpF recruitment
that straddle the TolB box (residues 35–39).
We next determined what effect these deletions had on the
cell killing activity of ColE9. Cultures of susceptible E. coli
JM83 cells were grown in shaking f lasks and the bactericidal
effects of the different ColE9S-S constructs monitored under
reducing conditions (Fig. 4). As previously published, oxidized
ColE9S-S has no cell killing activity, whereas the reduced form
of the toxin has wild-type biological activity (15). Reduced
1–60 ColE9S-SIm9 (Fig. 4) and 60–80 ColE9S-SIm9 were
both inactive. The former was expected because it lacks a TolB
box; however, the latter suggests that the loss of activity is due
to the inability to recruit OmpF. The reduced forms of 1–7
ColE9S-SIm9 and 1–30 ColE9S-SIm9, both of which contain
TolB boxes, had identical biological activities wherein cell
death took longer to initiate (Fig. 4). These data reveal that
deletion of OmpF contacting residues N-terminal to the TolB
box decreases porin recruitment and the efficiency of E. coli
cell killing, whereas removal of OmpF contacting sequences
C-terminal to the TolB box abolishes both.
Fig. 3. OmpF is recruited to the BtuBColE9S-SIm9 complex by the disor-
dered colicin T domain. Outer membrane protein complexes were ex-
tracted from E. coli BE3000 membranes and purified in the presence of full
length ColE9S-SIm9 (a), 1–316 ColE9S-SIm9 (b) or 1–83 ColE9S-SIm9 (c) and
loaded onto 1-ml Ni-charged HisTrap columns equilibrated in 20 mM TrisHCl,
pH 8.025 mM NaCl5 mM imidazole1% (wt/vol) -OG. The chromatograms
show protein complexes eluted from the column with a 5–300 mM imidazole
gradient, while monitoring the absorbance of the eluent at 280 nm, and have
been corrected for buffer contributions. In a and c, single peaks were ob-
served, whereas in b, two peaks eluted from the column, the latter most likely
due to a weakening of the interaction between ColE9 and BtuB in this deletion
construct. The 10% SDS-polyacrylamide gels adjacent to each chromatogram
include the peak fraction(s) from elution, the outer membrane extract loaded
onto each column, and controls of full-length or truncated colicins, BtuB and
OmpF. In all cases, BtuB and ColE9 were recovered but OmpF was lost when the
colicin lacked the disordered T domain. With the low percentage SDS-
polyacrylamide gels used to resolve extracted proteins, Im9 was not separated
from the dye front and is not observed. Bands in the eluted fractions were
excised, digested with trypsin, and the proteins identified unambiguously by
MALDI-TOF mass spectrometry (data not shown).
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Discussion
E Colicin R Domain Unfolding Likely Occurs After BtuB Receptor
Binding. The elongated structure of a colicin is thought to be
important in allowing the toxin to traverse the periplasm during
translocation. Because each coil in an enzymatic E colicin such
as ColE3 or ColE9 is 100 Å in length and the periplasm is 150
Å, then to span the periplasm, the coiled-coil regions linking the
R, T, and cell-killing domains must unfold or unfurl. Consistent
with such unfolding, a disulfide bond engineered across the
coiled-coil, but distal to the BtuB binding site, abolishes biolog-
ical activity of the colicin. A key question therefore is when such
unfolding occurs.
In their structure of the ColE3 R-domain bound to BtuB,
Kurisu et al. (12) observed a systematic increase in main-chain
displacement of the coiled-coil relative to the unbound state of
ColE3, and that the final 8–9 amino acids of each end of the R
domain were disordered. These observations were interpreted as
evidence of receptor-induced unfolding of the colicin coiled-coil.
We tested whether BtuB binding induces E colicin R-domain
unfolding through calorimetric measurements by using the na-
tive, intact ColE9Im9 complex in the presence and absence of
Ca2. The magnitudes of the enthalpic and entropic parameters
underpinning BtuBColE9Im9 complex formation are among
the largest found in the ITC literature for a protein–protein
interaction. Comparable figures have been reported for partially
or natively unstructured proteins that fold on binding to their
partner, where the observed H and S values are the summa-
tion of the energy changes of binding and folding (28, 29). X-ray
crystal structures have shown that R-domainBtuB complex
formation is accompanied by increased structure in the BtuB
extracellular loop regions, with residues 229–240 and 278–287
being resolved in the R135 bound form (12) but not the apo form
(13) of BtuB. The similarity of the thermodynamic parameters
for the equivalent BtuB complexes of wild-type and structurally
restrained ColE9S-SIm9 implies that any increase in rigidity or
structure is likely to be localized to the receptor itself. We
conclude from these data that the E colicin R domain does not
undergo receptor-induced unfolding.
How does an enzymatic E colicin unfold if not induced by
BtuB? We speculate that unfolding occurs after BtuB binding,
which necessitates that the toxin be actively displaced from its
primary receptor-binding site before cell entry. Because this
process would require an input of energy, such displacement
could provide an explanation as to why the energized Tol system
is coopted for colicin import. Furthermore, given that the tip of
the helical hairpin linking each of the coils forms the majority of
the interactions with BtuB, receptor displacement would permit
a fully extended R-domain structure to form, thereby allowing
the colicin to traverse the periplasm.
Assembly of a Colicin Translocon and the Role of Native Disorder. The
structural organization of the BtuBR-domain complex suggests
that BtuB itself is not involved in translocation (12). Colicin
binding does not displace the plug domain, which occludes
completely the central pore of the 22 -strand receptor, thereby
negating the pore as a possible route into the periplasm. In
addition, the toxin is positioned at a 45° angle relative to the
membrane surface, placing the cytotoxic and T domains away
from BtuB in a trajectory that suggests additional partners are
being sought to enable translocation (Fig. 1). We have demon-
strated that the porin OmpF is recruited directly to the
BtuBcolicin complex through a disordered T domain to form a
‘‘colicin translocon,’’ as had been postulated but not shown
previously. Binding of OmpF to BtuB-bound colicin appears to
be weak, which would explain why it has not been possible to
demonstrate the assembly of a similar complex simply by using
purified components that, for example, survives gel-filtration
chromatography (17). The success of the affinity purification
approach used in the present study is likely due to the in vivo
assembly of the ColE9Im9BtuB complex on the cell surface,
followed by the extraction of the entire complex from the same
membrane.
OmpF is one of the most abundant proteins in the bacterium
(100,000 copies per cell), whereas BtuB is expressed at very low
levels (200 copies per cell). Hence, enzymatic E colicins use
high-affinity binding to a rare outer membrane nutrient receptor
as a route for finding an abundant porin as a translocator.
Another important conclusion that can be reached about the
assembly of the colicin translocon is that it also occurs in the
absence of any unfolding of the coiled-coil R domain. Why is
OmpF recruited to the BtuBColE9Im9 complex, and how does
this association facilitate binding TolB in periplasm? Each
monomer of an OmpF trimer is a 16-stranded -barrel with a
central, water-filled transmembrane channel that allows the
passive diffusion of relatively small (	700 Da) hydrophilic
molecules across the outer membrane. At its narrowest point, the
OmpF pore is 7  11 Å (30), which is wide enough to allow the
passage of an unfolded polypeptide, such as the disordered T
domain of an enzymatic E colicin, into the periplasm. The
rationale for using OmpF in this way, apart from a lumen that
traverses the outer membrane, is that trimeric porins such as
OmpF are known to associate with TolB (31). Recruitment of
OmpF by a BtuB-bound colicin therefore ensures the toxin can
engage the energized Tol system.
Natively unfolded proteins are gaining an increasing promi-
nence in biology, shown to be important in cellular processes
such as signaling, transcription, and translation (32, 33). Char-
acterized by low sequence complexity (41% Gly and 17% Ser),
heteronuclear NMR spectroscopy has shown that the first 83
amino acids of the enzymatic E colicin T domain has the
conformational properties classically ascribed to natively disor-
dered polypeptides (25).
Native disorder provides the capacity for multiple binding
interactions because several linear epitopes can be accommo-
dated along the polypeptide chain. In the case of the ColE9 T
domain, the TolB box is located between residues 35–39 (34),
Fig. 4. Colicins deficient in OmpF recruitment are less effective at killing
E. coli K-12 cells. ColE9S-SIm9 and the T-domain deletions 1–7, 1–30, and
1–60 ColE9S-SIm9 were added to separate flasks of E. coli JM83 cells at the
point of inoculation (0 h). All cultures behaved identically until the addition of
DTT (5 mM) when the cultures had reached an optical density of 0.5 (as
indicated by the arrow), reducing the R-domain disulfide bond and, hence,
initiating cell killing. 1–60 was inactive in this assay, whereas full-length
ColE9S-SIm9 showed wild-type colicin cytotoxic activity. 1–7 and 1–30
ColE9S-SIm9 constructs had identical cell-killing profiles that were signifi-
cantly reduced relative to full-length Col.








with NMR showing the binding site extends to at least residue
43 (25). The present work suggests that, in addition, the disor-
dered T domain of an enzymatic colicin contains two regions
that comprise the OmpF binding site. One region is contained
within the first 7 amino acids of the disordered T domain,
supported by the work of Zakharov et al. (35), who have shown
these residues are important for blocking OmpF channels in
planar lipid bilayer experiments. The present work indicates the
loss of this site decreases OmpF recruitment to the colicin
translocon and reduces the efficiency of cell killing but does not
abolish it (Fig. 4). The second OmpF-binding site lies between
residues 54–80 as mapped through the ability of deletion con-
structs made in this study (1–38, 1–45, and 1–53 ColE9S-S
Im9) to recruit OmpF, whereas deletion of residues 1–60 or
60–80 of the colicin result in the loss of OmpF from the
translocon. Initial cross-linking studies to delineate this binding
site yet further suggest that the site includes residue 64 but does
not extend beyond residue 75 (N.G.H. and C.K., unpublished
results).
Immunity Protein Is Not Released During Formation of the Colicin
Translocon. Enzymatic E colicin cytotoxic domains are inacti-
vated in the producing host through the action of an immunity
protein that binds with fM affinity to the nuclease (36). The
heterodimeric colicinIm protein complex is then released into
the surrounding medium after lysis of the producing cell, induced
by a bacteriocin release lipoprotein. Part of our study addressed
the issue of whether the Im protein is dissociated at any point
during formation of the colicin translocon. We performed ITC
measurements on BtuB (Ca2) binding ColE9 that had been
stripped of its immunity protein and found that the thermody-
namic parameters were very similar to those of the het-
erodimeric complex (Table 1). Also, because the isolation of the
BtuBColE9Im9OmpF complex from the bacterial outer mem-
brane was accomplished by Ni-affinity purification utilizing a
hexa-histidine tag on Im9, we conclude that immunity proteins
are not released during formation of the colicin translocon.
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